Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Mus musculus | RAR-related orphan receptor gamma | Starlite/ChEMBL | No references |
Rattus norvegicus | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | Starlite/ChEMBL | No references |
Homo sapiens | nuclear factor, erythroid 2-like 2 | Starlite/ChEMBL | No references |
Homo sapiens | lysine (K)-specific demethylase 4E | Starlite/ChEMBL | No references |
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | GPCR family 2 | 0.0019 | 0.0012 | 0.0012 |
Toxoplasma gondii | histone lysine demethylase JMJC1/KDM5D/JARID1D | 0.0019 | 0 | 0.5 |
Loa Loa (eye worm) | jmjC domain-containing protein | 0.0071 | 0.5863 | 0.5863 |
Brugia malayi | hypothetical protein | 0.0043 | 0.2759 | 0.2759 |
Echinococcus granulosus | Transcription factor JmjC domain containing protein | 0.0071 | 0.5863 | 0.5863 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0019 | 0.0012 | 0.0012 |
Brugia malayi | jmjC domain containing protein | 0.0071 | 0.5863 | 0.5863 |
Echinococcus multilocularis | lysine specific demethylase 5A | 0.0071 | 0.5863 | 0.5863 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0019 | 0.0012 | 0.0012 |
Schistosoma mansoni | jumonji domain containing protein | 0.0071 | 0.5863 | 0.5863 |
Entamoeba histolytica | protein kinase, putative | 0.0108 | 1 | 1 |
Trypanosoma cruzi | CMGC/DYRK protein kinase, putative | 0.0108 | 1 | 1 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.4645 | 0.4645 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0019 | 0.0012 | 0.0012 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0012 | 0.0012 |
Entamoeba histolytica | protein kinase, putative | 0.0108 | 1 | 1 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0019 | 0.0012 | 0.0012 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0043 | 0.2759 | 0.2759 |
Loa Loa (eye worm) | CMGC/DYRK/DYRK1 protein kinase | 0.0108 | 1 | 1 |
Echinococcus multilocularis | Transcription factor, JmjC domain containing protein | 0.0071 | 0.5863 | 0.5863 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.4645 | 0.4645 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.4645 | 0.4645 |
Trypanosoma brucei | CMGC/DYRK protein kinase, putative | 0.0108 | 1 | 1 |
Echinococcus granulosus | lysine specific demethylase 5A | 0.0071 | 0.5863 | 0.5863 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0108 | 1 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0108 | 1 | 1 |
Toxoplasma gondii | histone lysine demethylase JMJD6a | 0.0019 | 0 | 0.5 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0019 | 0.0012 | 0.0012 |
Schistosoma mansoni | hypothetical protein | 0.0041 | 0.25 | 0.25 |
Plasmodium vivax | JmjC domain containing protein | 0.0019 | 0 | 0.5 |
Schistosoma mansoni | jumonji/arid domain-containing protein | 0.0071 | 0.5863 | 0.5863 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0012 | 0.0012 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0012 | 0.0012 |
Trypanosoma cruzi | CMGC/DYRK protein kinase, putative | 0.0108 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.4645 | 0.4645 |
Echinococcus granulosus | dual specificity | 0.0108 | 1 | 1 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0019 | 0.0012 | 0.0012 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0043 | 0.2759 | 0.2759 |
Loa Loa (eye worm) | hypothetical protein | 0.0107 | 0.9937 | 0.9937 |
Plasmodium falciparum | JmjC domain-containing protein, putative | 0.0019 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.25 | 0.25 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0041 | 0.25 | 0.25 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0012 | 0.0012 |
Schistosoma mansoni | hypothetical protein | 0.0043 | 0.2759 | 0.2759 |
Echinococcus multilocularis | GPCR, family 2 | 0.0019 | 0.0012 | 0.0012 |
Brugia malayi | jmjC domain containing protein | 0.0071 | 0.5863 | 0.5863 |
Echinococcus multilocularis | dual specificity | 0.0108 | 1 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0108 | 1 | 1 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0019 | 0.0012 | 0.0012 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0043 | 0.2759 | 0.2759 |
Leishmania major | serine/threonine-protein kinase, putative,protein kinase, putative | 0.0108 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0012 | 0.0012 |
Schistosoma mansoni | jumonji/arid domain-containing protein | 0.0071 | 0.5863 | 0.5863 |
Loa Loa (eye worm) | hypothetical protein | 0.0107 | 0.9937 | 0.9937 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
AC50 (binding) | = 3.211 uM | PUBCHEM_BIOASSAY: MLPCN Dyrk1A Kinase Measured in Biochemical System Using Plate Reader - 2124-01_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504442] | ChEMBL. | No reference |
Potency (functional) | 1.6511 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 8.9125 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 10.4179 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 17.7828 um | PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 18.3564 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | = 19.9526 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 23.1093 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] | ChEMBL. | No reference |
Potency (functional) | 23.1093 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 25.1189 uM | PubChem BioAssay. Inhibitors of USP1/UAF1: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 29.0929 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (binding) | = 31.6228 um | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ] | ChEMBL. | No reference |
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase). (Class of assay: confirmatory) [Related pubchem assays: 2429 (Confirmation qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2407 (Probe Development Summary for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2427 (Thermal Shift Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase))] | ChEMBL. | No reference |
Potency (functional) | = 35.4813 um | PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 35.4813 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] | ChEMBL. | No reference |
Potency (functional) | = 44.6684 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase Cleavage of Glycogen. (Class of assay: confirmatory) [Related pubchem assays: 1473, 1466 ] | ChEMBL. | No reference |
Potency (functional) | 70.7946 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391] | ChEMBL. | No reference |
Potency (functional) | 79.4328 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.